Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma.
Nov 2007 - Clin. Immunol.; 125(3):1521-6616 [PMID:17916447]
[Kim JH] [Lee Y] [Bae YS] [Kim WS] [Kim K] [Im HY] [Kang WK] [Park K] [Choi HY] [Lee HM] [Baek SY] [Lee H] [Doh H] [Kim BM] [Kim CY] [Jeon C] [Jung CW]

DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors.
Aug 2007 - Cancer Immunol. Immunother.; 56(11):0340-7004 [PMID:17443323]
[Lim DS] [Kim JH] [Lee DS] [Yoon CH] [Bae YS]